10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership12,893 shares
Latest Disclosed Value $ 273,718
Victory Capital Management Inc reports 0.07% decrease in ownership of TXG / 10x Genomics, Inc.

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 12,893 shares of 10x Genomics, Inc. (MX:TXG) valued at $273,718 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 12,902 shares of 10x Genomics, Inc.. This represents a change in shares of -0.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10X GENOMICS COM 88025U109 12,893 -9 -0.07 274 30.00 0.0001
2026-02-13 2025-12-31 13F 10X GENOMICS COM 88025U109 12,902 186 1.46 210 41.89 0.0001
2025-11-12 2025-09-30 13F 10X GENOMICS COM 88025U109 12,716 379 3.07 149 4.23 0.0001
2025-08-13 2025-06-30 13F 10X GENOMICS COM 88025U109 12,337 101 0.83 143 33.96 0.0001
2025-05-02 2025-03-31 13F 10X GENOMICS COM 88025U109 12,236 -102 -0.83 107 -40.11 0.0001
2025-02-06 2024-12-31 13F 10X GENOMICS COM 88025U109 12,338 -299 -2.37 177 -37.89 0.0002
2024-11-05 2024-09-30 13F 10X GENOMICS COM 88025U109 12,637 -91 -0.71 285 15.38 0.0003
2024-08-05 2024-06-30 13F 10X GENOMICS COM 88025U109 12,728 -203 -1.57 248 -49.07 0.0002
2024-05-03 2024-03-31 13F 10X GENOMICS COM 88025U109 12,931 193 1.52 485 -31.88 0.0005
2024-02-05 2023-12-31 13F 10X GENOMICS COM 88025U109 12,738 2,515 24.60 713 69.12 0.0007
2023-11-06 2023-09-30 13F 10X GENOMICS COM 88025U109 10,223 -16,261 -61.40 422 -71.52 0.0005
2023-07-27 2023-06-30 13F 10X GENOMICS COM 88025U109 26,484 -1,241 -4.48 1,479 -4.40 0.0016
2023-05-02 2023-03-31 13F 10X GENOMICS COM 88025U109 27,725 18,017 185.59 1,547 337.96 0.0017
2023-04-25 2022-12-31 13F/A-3 10X GENOMICS COM 88025U109 9,708 -5 -0.05 354 27.44 0.0004
2023-03-10 2022-12-31 13F/A-2 10X GENOMICS COM 88025U109 9,708 -5 354 0.0002
2023-02-10 2022-12-31 13F/A-1 10X GENOMICS COM 88025U109 9,708 -5 354 0.0002
2023-02-09 2022-12-31 13F 10X GENOMICS COM 88025U109 9,620 -93 451 0.0003
2022-11-02 2022-09-30 13F 10X GENOMICS COM 88025U109 9,713 9,713 277 0.0003
2022-05-04 2022-03-31 13F 10X GENOMICS COM 88025U109 0 -23,560 -100.00 0 -100.00
2022-02-07 2021-12-31 13F 10X GENOMICS COM 88025U109 23,560 -21,455 -47.66 3,509 -46.46 0.0032
2021-11-02 2021-09-30 13F 10X GENOMICS COM 88025U109 45,015 -8,584 -16.02 6,554 -37.56 0.0064
2021-08-03 2021-06-30 13F 10X GENOMICS COM 88025U109 53,599 -124,652 -69.93 10,496 -67.47 0.0101
2021-05-04 2021-03-31 13F 10X GENOMICS COM 88025U109 178,251 -2,381 -1.32 32,263 26.14 0.0331
2021-02-01 2020-12-31 13F 10X GENOMICS COM 88025U109 180,632 -23,584 -11.55 25,578 0.46 0.0285
2020-11-09 2020-09-30 13F 10X Genomics COM 88025U109 204,216 -27,053 -11.70 25,461 23.27 0.0327
2020-08-07 2020-06-30 13F 10X GENOMICS COM 88025U109 231,269 -126,970 -35.44 20,654 -7.48 0.0280
2020-05-12 2020-03-31 13F/A-1 10X GENOMICS COM 88025U109 358,239 -96,655 -21.25 22,325 -35.64 0.0374
2020-05-04 2020-03-31 13F 10X GENOMICS COM 88025U109 358,239 -96,655 22,325 24,432.4439
2020-02-06 2019-12-31 13F/A-1 10X GENOMICS COM 88025U109 454,894 -106,780 -19.01 34,686 22.53 0.0421
2020-02-04 2019-12-31 13F 10X GENOMICS COM 88025U109 449,756 41,103
2019-11-12 2019-09-30 13F 10X GENOMICS COM 88025U109 561,674 561,674 28,308 0.0364
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.